Many people starting semaglutide experience mild nausea or a decreased thirst drive
[7] [8] Oral semaglutide increases levothyroxine exposure, so thyroid function monitoring is recommended in patients taking both medications
22 This highlights the importance of continuous pharmacist involvement to assess tolerability, determine when dose adjustments or therapy changes are warranted, and guide patients through individualized management strategies
Semaglutide, as a weight loss treatment, is usually administered once a week
Active device-based approaches, including microneedle patches, jet injectors, and ultrasound-enhanced delivery systems, are expanding the range of peptides amenable to this route ( Malhotra et al., 2025
Lastly, induction of CYP2B, 2C, and 3A was evaluated immunochemically by immunoblotting in male and female patas and cynomologus monkeys treated with phenobarbital (Jones and Lubet 1992)